VD
Vamil Divan Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
44
Avg Return
Past Year
Past Year
21%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $124 |
46%
upside
| 2 | +7.4% |
0
%
| 16 Jan ‘26 yesterday |
|
|
|
Buy
Maintained
| $221 |
37%
upside
| 1 | +25% |
0
%
| 18 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $227 |
4%
upside
| 1 | +12% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $35 |
36%
upside
| 1 | -0.06% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $17 |
16%
upside
| 1 | +52% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
277%
upside
| 1 | +31% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $3 |
362%
upside
| 1 | -14% |
0
%
| 28 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $242 |
13%
upside
| 1 | +3.7% |
0
%
| 20 Oct ‘25 2 months ago |
|